Nicolet Bankshares Inc. Sells 633 Shares of Danaher Co. (NYSE:DHR)

Nicolet Bankshares Inc. trimmed its position in shares of Danaher Co. (NYSE:DHRFree Report) by 9.6% during the third quarter, HoldingsChannel.com reports. The firm owned 5,927 shares of the conglomerate’s stock after selling 633 shares during the period. Nicolet Bankshares Inc.’s holdings in Danaher were worth $1,470,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the business. AXS Investments LLC raised its position in Danaher by 1.4% during the second quarter. AXS Investments LLC now owns 2,780 shares of the conglomerate’s stock valued at $667,000 after buying an additional 39 shares during the period. Bank of Hawaii raised its position in Danaher by 0.3% during the second quarter. Bank of Hawaii now owns 12,578 shares of the conglomerate’s stock valued at $3,019,000 after buying an additional 42 shares during the period. Personal CFO Solutions LLC raised its position in Danaher by 1.6% during the second quarter. Personal CFO Solutions LLC now owns 2,729 shares of the conglomerate’s stock valued at $655,000 after buying an additional 43 shares during the period. Nations Financial Group Inc. IA ADV raised its position in Danaher by 0.8% during the first quarter. Nations Financial Group Inc. IA ADV now owns 6,064 shares of the conglomerate’s stock valued at $1,779,000 after buying an additional 46 shares during the period. Finally, Mirova raised its position in Danaher by 1.1% during the second quarter. Mirova now owns 4,159 shares of the conglomerate’s stock valued at $998,000 after buying an additional 46 shares during the period. Institutional investors own 76.71% of the company’s stock.

Danaher Stock Performance

NYSE DHR traded up $3.08 during trading on Monday, reaching $246.03. 940,675 shares of the company’s stock were exchanged, compared to its average volume of 3,007,432. The business has a 50 day moving average price of $231.21 and a 200-day moving average price of $231.53. The stock has a market capitalization of $181.80 billion, a P/E ratio of 38.11, a PEG ratio of 3.67 and a beta of 0.85. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.68 and a quick ratio of 1.37. Danaher Co. has a fifty-two week low of $182.09 and a fifty-two week high of $249.89.

Danaher (NYSE:DHRGet Free Report) last issued its quarterly earnings data on Tuesday, January 30th. The conglomerate reported $2.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.91 by $0.18. Danaher had a return on equity of 12.25% and a net margin of 17.26%. The company had revenue of $6.41 billion during the quarter, compared to analysts’ expectations of $6.10 billion. During the same quarter in the previous year, the company posted $2.87 earnings per share. The business’s revenue was down 10.2% on a year-over-year basis. Sell-side analysts forecast that Danaher Co. will post 7.67 earnings per share for the current fiscal year.

Danaher Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, January 26th. Investors of record on Friday, December 29th were given a dividend of $0.24 per share. This represents a $0.96 dividend on an annualized basis and a yield of 0.39%. The ex-dividend date was Thursday, December 28th. Danaher’s dividend payout ratio is currently 15.02%.

Insider Buying and Selling

In other Danaher news, Director Teri List sold 3,289 shares of the firm’s stock in a transaction on Tuesday, February 6th. The stock was sold at an average price of $248.32, for a total value of $816,724.48. Following the sale, the director now owns 19,726 shares of the company’s stock, valued at approximately $4,898,360.32. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 11.10% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several brokerages have weighed in on DHR. Barclays lowered Danaher from an “overweight” rating to an “equal weight” rating and set a $240.00 target price on the stock. in a research report on Wednesday, January 24th. JPMorgan Chase & Co. upped their target price on Danaher from $250.00 to $270.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 20th. Raymond James upped their target price on Danaher from $240.00 to $270.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 31st. Citigroup upped their target price on Danaher from $255.00 to $280.00 and gave the stock a “buy” rating in a research report on Wednesday, January 31st. Finally, StockNews.com downgraded Danaher from a “buy” rating to a “hold” rating in a research note on Wednesday, January 31st. Seven research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $266.00.

Check Out Our Latest Stock Report on Danaher

Danaher Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions.

Featured Articles

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.